Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway

<collab>Journal of Cancer</collab>

doi:10.7150/jca.67290



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2021; 12(23):6948. doi:10.7150/jca.67290 This issue Cite

Retraction

Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway

Journal of Cancer

Citation:

Journal of Cancer. Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. J Cancer 2021; 12(23):6948. doi:10.7150/jca.67290. https://www.jcancer.org/v12p6948.htm

Other styles

Retracted-article in J Cancer, Volume 10, 6511

Citation styles

APA

Journal of Cancer (2021). Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. Journal of Cancer, 12(23), 6948. https://doi.org/10.7150/jca.67290.

ACS

Journal of Cancer Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. J. Cancer 2021, 12 (23), 6948. DOI: 10.7150/jca.67290.

NLM

CSE

Journal of Cancer. 2021. Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. J Cancer. 12(23):6948.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.